Flow cytometric immunphenotyping of epithelial cancer cells in effusions - Technical considerations and pitfalls

Cytometry Part B - Clinical Cytometry

Volumn 72, Issue 5, 2007, Pages 332-343

  Dong, Hiep P ^a   Holth, Arild ^a   Berner, Aasmund ^a   Davidson, Ben ^a   Risberg, Björn ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Carcinorma; Effusions; Flow cytometry; Immunhistochemistry; Mesothelioma

Indexed keywords

ANTIBODY; BIOLOGICAL MARKER; CELL ADHESION MOLECULE; INTEGRIN; SYNDECAN 1; DIAGNOSTIC AGENT; MEMBRANE ANTIGEN; TUMOR MARKER;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; EFFUSION; EPITHELIUM CELL; FLOW CYTOMETRY; FROZEN SECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INTERMETHOD COMPARISON; MESOTHELIOMA; PERITONEAL FLUID; PLEURA EFFUSION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; ANTIBODY SPECIFICITY; ARTIFACT; ASCITES FLUID; BIOSYNTHESIS; CARCINOMA; CRYOPRESERVATION; EPITHELIUM; HISTOLOGY; IMMUNOLOGY; METHODOLOGY; MICROTOMY; PATHOLOGY; PREDICTION AND FORECASTING; STANDARD; TUMOR CELL LINE;

ANTIBODIES; ANTIBODY SPECIFICITY; ANTIGENS, SURFACE; ARTIFACTS; ASCITIC FLUID; BIOLOGICAL MARKERS; CARCINOMA; CELL LINE, TUMOR; CRYOPRESERVATION; EPITHELIAL CELLS; EPITHELIUM; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; MICROTOMY; PLEURAL EFFUSION, MALIGNANT; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TISSUE EMBEDDING; TUMOR MARKERS, BIOLOGICAL;

EID: 35748978560     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20172     Document Type: Article

References (46)

1. US-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry. Bethesda, MD, USA, November 16-17, 1995. Cytometry 1997;30:213-274.
2. Orfao A, Schmitz G, Brando B, Arguelles A, Basso G, Braylan R, Rothe G, Lacombe G, Lanza F, Papa S, Lucio P, San Miguel JF. Clinically useful information provided by the flow immunophenotyping of hematological malignancies: Current status and future directions. Clin Chem 1999;45:1708-1717.
3. Dunphy CH. Applications of flow cytometry and immunohistochemistry to diagnostic hematopathology. Arch Pathol Lab Med 2004;128:1004-1022.
4. Bedrossian CWM. Diagnostic problems in serous effusions. Diagn Cytopathol 1998;19:131-137.
5. Fetsch PA, Abati A. Immunocytochemistry in effusion cytology: A contemporary review. Cancer Cytopathol 2001;93:293-308.
6. Ordonez NG. Immunohistochemical diagnosis of epitheloid mesotheliomas: A critical review of old markers, new markers. Hum Pathol 2002;33:953-967.
7. Mohanty SK, Dey P. Serous effusions: Diagnosis of malignancy beyond cytomorphology. An analytic review. Postgrad Med J 2003;79:569-574.
8. Chen LM, Lazcano O, Katzmann JA, Kimlinger TK, Li CY. The role of conventional cytology, immunocytochemistry, and flow cytometric DNA ploidy in evaluation of body cavity fluids: A prospective study of 52 patients. Am J Clin Pathol 1998;109:712-721.
9. Schneller J, Eppich E, Greenebaum E, Elequin F, Sherman A, Wersto R, Koss LG. Flow cytometry and Feulgen cytophotometry in evaluation of effusions. Cancer 1987;59:1307-1313.
10. Unger KM, Raber M, Bedrossian CW, Stein DA, Barlogie B. Analysis of pleural effusions using automated flow cytometry. Cancer 1983:52:873-877.
11. Krishan A, Ganjei-Azar P, Jorda M, Hamelik RM, Reis IM, Nadji M. Detection of tumor cells in body cavity fluids by flow cytometric and immuncytochemical analysis. Diagn Cytopathol 2006;34:528-541.
12. Ceyhan BB, Demiralp E, Celikel T. Analysis of pleural effusions using flow cytometry. Respiration 1996;63:17-24.
13. Sikora J, Dworacki G, Trybus M, Batura-Gabryel H, Zeromski J. Correlation between DNA content, expression of Ki-67 antigen of tumor cells and immunophenotype of lymphocytes from malignant pleural effusions. Tumour Biol 1998;19:196-204.
14. Risberg B, Davidson B, Dong HP, Nesland JM, Berner A. Flow cytometric immunophenotyping of serous effusions and peritoneal washings - Comparison with immunocytometry and morphological findings. J Clin Pathol 2000;53:513-517.
15. Risberg B, Davidson B, Nielsen S, Dong HP, Christensen J, Johansen P, Asschenfeldt P, Berner A. Detection of monocyte/macrophage cell populations in effusions - A comparative study using flow cytometric immunophenotyping and immunocytochemistry. Diagn Cytopathol 2001;25:214-219.
16. Davidson B, Dong HP, Berner A, Christensen J, Nielsen S, Johansen P, Bryne M, Asschenfeldt P, Risberg B. Detection of malignant epithelial cells in effusions using flow cytometric immunophenotyping. An analysis of 92 cases. Am J Clin Pathol 2002;118:85-92.
17. Kraan J, Gratama JW, Keeney M, D'Hautcourt JL. Setting up and calibration of a flow cytometer for multicolor immunophenotyping. J Biol Regul Homeost Agents 2003;17:223-233.
18. Bryson GJ, Lear D, Williamson R, Wong RC. Detection of the CD56+/CD45- immunophenotype by flow cytometry in neuroendocrine malignancies. J Clin Pathol 2002;55:535-537.
19. Chang A, Benda PM, Wood BL, Kussick SJ. Lineage-specific identification of nonhematopoietic neoplasms by flow cytometry. Am J Clin Pathol 2003;119:643-655.
20. Baumgarth N, Roederer M. A practical approach to multicolor flow cytometry for immunophenotyping. J Immunol Methods 2000;243:77-97.
21. Stewart CC, Stewart SJ. Four color compensation. Cytometry 1999;38:161-175.
22. Stewart CC, Stewart SJ. Titering antibodies. In: Robinson JP, Darzynkiewicz Z, Dean NP, Dressier GL, Rabinowitch SP, Stewart CC, Tanke JH, Wheeless LL, editors. Current Protocols in Cytometry. New York: Wiley; 1997. pp 4.1.1-4.1.13.
23. Stewart CC, Stewart SJ. Phenotypic analysis. In: Robinson JP, Darzynkiewicz Z, Dean NP, Dressier GL, Rabinowitch SP, Stewart CC, Tanke JH, Wheeless LL, editors. Current Protocols in Cytometry. New York: Wiley; 1997. pp 6.0.1-6.2.18.
24. Fiebig EW, Johnson DK, Hirschkorn DF, Knape CC, Webster HK, Lowder J, Busch MP. Lymphocyte subset analysis on frozen whole blood. Cytometry 1997;29:340-350.
25. Sleasman JW, Leon BH, Aleixo LF, Rojas M, Goodenow MM. Immunomagnetic selection of purified monocyte and lymphocyte populations from peripherial blood mononuclear cells following cryopreservation. Clin Diagn Lab Immunol 1997;4:653-658.
26. Lanza F, Moretti S, Castagnari B, Montanelli F, Latorraca A, Ferrari L, Bardi A, Dominici M, Campioni D, Dabusti M, Piva N, Lodi G, Reverberi R, Castoldi G. Assessment of distribution of CD34 epitope classes in fresh and cryopreserved peripheral blood progenitor cells and acute myeloid leukemic blasts. Haematologica 1999;84:969-977.
27. Deneys V, Thiry V, Hougardy N, Mazzon AM, Leveugle P, De Bruyere M. Impact of cryopreservation on B cell chronic lymphocytic leukaemia phenotype. J Immunol Methods 1999;228:13-21.
28. Davidson B, Risberg B, Kristensen G, Kvalheim G, Emilsen E, Bjamer A, Berner A. Detection of cancer cells in effusions from patients diagnosed with gynecological malignancies - Evaluation of five epithelial markers. Virchows Arch 1999;435:43-49.
29. Davidson B, Nielsen S, Christensen J, Asschenfeldt P, Berner A, Risberg B, Johansen P. The role of Desmin and N-cadherin in effusion cytology. A comparative study using established markers of mesothelial and epithelial cells. Am J Surg Pathol 2001;25:1405-1412.
30. Cruet S, Salamanca C, Mitchell GW, Auersperg N. αvβ3 and vitronectin expression by normal ovarian surface epithelial cells: Role in cell adhesion and cell proliferation. Gynecol Oncol 1999;75:254-260.
31. Liapis H, Hutton K. Detection of integrins in formalin-fixed, paraffin-embedded tissues. J Histochem Cytochem 1997;45:737-741.
32. Barth TF, Rinaldi N, Bruderlein S, Mechtersheimer G, Strater J, Altevogt P, Moller P. Mesothelial cells in suspension expose an enriched integrin repertoire capable of capturing soluble fibronectin and laminin. Cell Commun Adhes 2002;9:1-14.
33. Carreiras F, Lehmann M, Sichel F, Marvaldi J, Gauduchon P, Le Talaer JY. Implication of the αvβ3 integrin in the adhesion of the ovarian-adenocarcinoma cell line IGROV1. Int J Cancer 1995;63:530-536.
34. Skubitz AP, Bast RC Jr, Wayner EA, Letourneau PC, Wilke MS. Expression of α6 and β4 integrins in serous ovarian carcinoma correlates with expression of the basement membrane protein laminin. Am J Pathol 1996;148:1445-1461.
35. Davidson B, Goldberg I, Reich R, Tell L, Dong HP, Trope' CG, Risberg B, Kopolovic J. αV- and β1-integrin subunits are commonly expressed in malignant effusions from ovarian carcinoma patients. Gynecol Oncol 2003;90:248-257.
36. Calvo F, Martin PM, Jabrane N, De Cremoux P, Magdelenat H. Human breast cancer cells share antigens with the myeloid monocyte lineage. Br J Cancer 1987;1:15-19.
37. Ordonez NG. The immunohistochemical diagnosis of mesothelioma: A comparative study of epithelioid mesothelioma and lung adenocarcinoma. Am J Surg Pathol 2003;27:1031-1051.
38. Roberts F, Harper CM, Downie I, Burnett RA. Immunohistochemical analysis still has a limited role in the diagnosis of malignant mesothelioma. A study of thirteen antibodies. Am J Clin Pathol 2001;116:253-262.
39. Beauvais DM, Burbach BJ, Rapraeger AC. The syndecan-1 ectodomain regulates αvβ3 integrin activity in human mammary carcinoma cells. J Cell Biol 2004;167:171-181.
40. Barbareschi M, Maisonneuve P, Aldovini D, Cangi MG, Pecciarini L, Angelo Mauri F, Veronese S, Caffo O, Lucenti A, Palma PD, Galligioni E, Doglioni C. High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis. Cancer 2003;98:474-483.
41. Gulyas M, Hjerpe A. Proteoglycans and WT1 as markers for distinguishing adenocarcinoma, epithelioid mesothelioma, and benign mesothelium. J Pathol 2003;199:479-487.
42. Dejmek A, Hjerpe A. Reactivity of six antibodies in effusions of mesothelioma, adenocarcinoma and mesotheliosis: Stepwise logistic regression analysis. Cytopathology 2000;11:8-17.
43. Shield PW, Callan JJ, Devine PL. Markers for metastatic adenocarcinoma in serous effusion specimens. Diagn Cytopathol 1994;11:237-245.
44. Sigstad E, Dong HP, Nielsen S, Berner A, Davidson B, Risberg B. Quantitative analysis of integrin expression in effusions using flow cytometric immunophenotyping. Diagn Cytopathol 2005;33:321-331.
45. Dong HP, Bunkholt Elstrand M, Holth A, Silins I, Berner A, Trope' CG, Davidson B, Risberg B. NK and B cell infiltration correlates with worse outcome in metastatic ovarian carcinoma. Am J Clin Pathol 2006;125:451-458.
46. Davidson B, Dong HP, Holth A, Berner A, Risberg B. Chemokine receptors are infrequently expressed in malignant or benign mesothelial cells. Am J Clin Pathol (in press).